Strides Pharma moves up as its arm acquires Neviton Softech
Strides Pharma Science is currently trading at Rs. 885.20, up by 4.65 points or 0.53% from its previous closing of Rs. 880.55 on the BSE.
The scrip opened at Rs. 880.60 and has touched a high and low of Rs. 908.85 and Rs. 873.50 respectively. So far 3947 shares were traded on the counter.
The BSE group 'A' stock of face value Rs. 10 has touched a 52 week high of Rs. 1024.90 on 03-Nov-2025 and a 52 week low of Rs. 551.00 on 07-Apr-2025.
Last one week high and low of the scrip stood at Rs. 908.85 and Rs. 848.25 respectively. The current market cap of the company is Rs. 8159.13 crore.
The promoters holding in the company stood at 27.86%, while Institutions and Non-Institutions held 42.55% and 29.59% respectively.
Strides Pharma Science’s wholly owned subsidiary -- Arco Lab has completed the acquisition of Neviton Softech (Neviton). Neviton is engaged in providing IT services and engineering solutions to a diverse range of businesses. Neviton’s core expertise includes developing machine interfaces through IoT devices and integrating live data feeds into real time applications. Arco Lab had previously acquired a 25% equity stake in Neviton in August 2022, followed by an additional 25% stake in January 2024. Pursuant to the current transaction, Arco Lab has acquired the remaining 50% equity interest in Neviton. Subsequently, the Neviton has become a wholly owned subsidiary of Arco Lab and step-down subsidiary of the company with effect from February 16, 2026. The 50% stake in Neviton has been acquired for a consideration of 2 million euros or around Rs 21.77 crore.
Arco Lab was established to provide best-in-class business services in driving business and IT transformation, cost efficiencies and operational excellence and serve as a Global Life Science Capability Centre. Arco Lab also provides IT Infrastructure services, Enterprise Application Services, Manufacturing IT Services, New Technologies and Cybersecurity services. With the investment, Neviton and Arco Lab synergize their strengths and enables Arco Lab to offer better knowledge-based and IT services ensuring higher scale, scope and significant cash savings and enable better internal group wise digitization process. Accordingly, Neviton’s acquisition is complementary to Arco Lab’s business objectives.
